inviragen
Inviragen Advances Dengue Vaccine Into Second Stage Of Phase II Study
Inviragen, Inc. has initiated the second stage of an ongoing Phase II study of DENVax™, its investigational dengue vaccine.
Vabiotech Licenses Japanese Encephalitis Technology From Inviragen
Vietnam's VABIOTECH has acquired rights to Inviragen's proprietary Japanese encephalitis technology to produce a cell-derived vaccine.
Inviragen Initiates Phase I Study Of Hand, Foot And Mouth Disease Vaccine
Inviragen announced this week the initiation of the first clinical trial of its Hand, Foot and Mouth Disease investigational vaccine in Singapore.
